Literature DB >> 29601978

Prolactin regulatory element-binding (PREB) protein regulates hepatic glucose homeostasis.

Joo-Man Park1, Mi-Young Kim1, Tae-Hyun Kim1, Dong-Kook Min1, Ga Eul Yang1, Yong-Ho Ahn2.   

Abstract

Prolactin regulatory element-binding (PREB) protein is a transcription factor that regulates prolactin (PRL) gene expression. PRL, also known as luteotropic hormone or luteotropin, is well known for its role in producing milk. However, the role of PREB, in terms of hepatic glucose metabolism, is not well elucidated. Here, we observed expression of Preb in the mouse liver, in connection with glucose homeostasis. Morevoer, Preb was downregulated in db/db, ob/ob and high-fat diet-induced obese (DIO) mice, concurrent with upregulation of the liver genes glucose-6-phosphatase (G6pc) and phosphoenolpyruvate carboxykinase-1 (Pck). Administration of adenovirus-Preb (Ad-Preb) to db/db, ob/ob, and DIO mice diminished glucose, insulin, and pyruvate tolerance, which analogously, were impaired in normal (C57BL/6) mice knocked down for Preb, via infection with Ad-shPreb (anti-Preb RNA), indicating Preb to be a negative regulator of liver gluconeogenic genes. We further demonstrate that Preb negatively influences gluconeogenic gene expression, by directly binding to their promoters at a prolactin core-binding element (PCBE). A better understanding of Preb gene expression, during the pathogenesis of hepatic insulin resistance, could ultimately provide new avenues for therapies for metabolic syndrome, obesity, and type-2 diabetes mellitus, disorders whose worldwide incidences are increasing drastically.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gluconeogenesis; Prolactin core-binding element; Prolactin element-binding protein; Type-2 diabetes mellitus

Mesh:

Substances:

Year:  2018        PMID: 29601978     DOI: 10.1016/j.bbadis.2018.03.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  3 in total

1.  Predicting master transcription factors from pan-cancer expression data.

Authors:  Jessica Reddy; Marcos A S Fonseca; Rosario I Corona; Robbin Nameki; Felipe Segato Dezem; Isaac A Klein; Heidi Chang; Daniele Chaves-Moreira; Lena K Afeyan; Tathiane M Malta; Xianzhi Lin; Forough Abbasi; Alba Font-Tello; Thais Sabedot; Paloma Cejas; Norma Rodríguez-Malavé; Ji-Heui Seo; De-Chen Lin; Ursula Matulonis; Beth Y Karlan; Simon A Gayther; Bogdan Pasaniuc; Alexander Gusev; Houtan Noushmehr; Henry Long; Matthew L Freedman; Ronny Drapkin; Richard A Young; Brian J Abraham; Kate Lawrenson
Journal:  Sci Adv       Date:  2021-11-24       Impact factor: 14.136

2.  Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes.

Authors:  Jingya Lyu; Hitomi Imachi; Kensaku Fukunaga; Seisuke Sato; Toshihiro Kobayashi; Tao Dong; Takanobu Saheki; Mari Matsumoto; Hisakazu Iwama; Huanxiang Zhang; Koji Murao
Journal:  Mol Metab       Date:  2020-01-07       Impact factor: 7.422

Review 3.  Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D2 Dopamine Receptor (D2-R) Isoforms.

Authors:  Kaja Blagotinšek Cokan; Maša Mavri; Catrin Sian Rutland; Sanja Glišić; Milan Senćanski; Milka Vrecl; Valentina Kubale
Journal:  Biomolecules       Date:  2020-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.